These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. SARS-CoV-2 Infection of Human Neurons Is TMPRSS2 Independent, Requires Endosomal Cell Entry, and Can Be Blocked by Inhibitors of Host Phosphoinositol-5 Kinase. Kettunen P; Lesnikova A; Räsänen N; Ojha R; Palmunen L; Laakso M; Lehtonen Š; Kuusisto J; Pietiläinen O; Saber SH; Joensuu M; Vapalahti OP; Koistinaho J; Rolova T; Balistreri G J Virol; 2023 Apr; 97(4):e0014423. PubMed ID: 37039676 [TBL] [Abstract][Full Text] [Related]
10. Design of a bifunctional pan-sarbecovirus entry inhibitor targeting the cell receptor and viral fusion protein. Jin H; Cheng L; Gong Y; Zhu Y; Chong H; Zhang Z; He Y J Virol; 2023 Aug; 97(8):e0019223. PubMed ID: 37578234 [TBL] [Abstract][Full Text] [Related]
11. Kidney organoids reveal redundancy in viral entry pathways during ACE2-dependent SARS-CoV-2 infection. Vanslambrouck JM; Neil JA; Rudraraju R; Mah S; Tan KS; Groenewegen E; Forbes TA; Karavendzas K; Elliott DA; Porrello ER; Subbarao K; Little MH J Virol; 2024 Mar; 98(3):e0180223. PubMed ID: 38334329 [TBL] [Abstract][Full Text] [Related]
12. Metalloproteinase-Dependent and TMPRSS2-Independent Cell Surface Entry Pathway of SARS-CoV-2 Requires the Furin Cleavage Site and the S2 Domain of Spike Protein. Yamamoto M; Gohda J; Kobayashi A; Tomita K; Hirayama Y; Koshikawa N; Seiki M; Semba K; Akiyama T; Kawaguchi Y; Inoue JI mBio; 2022 Aug; 13(4):e0051922. PubMed ID: 35708281 [TBL] [Abstract][Full Text] [Related]
13. Nonmuscle myosin heavy chain IIA facilitates SARS-CoV-2 infection in human pulmonary cells. Chen J; Fan J; Chen Z; Zhang M; Peng H; Liu J; Ding L; Liu M; Zhao C; Zhao P; Zhang S; Zhang X; Xu J Proc Natl Acad Sci U S A; 2021 Dec; 118(50):. PubMed ID: 34873039 [TBL] [Abstract][Full Text] [Related]
14. Targeting the Fusion Process of SARS-CoV-2 Infection by Small Molecule Inhibitors. Park SB; Irvin P; Hu Z; Khan M; Hu X; Zeng Q; Chen C; Xu M; Leek M; Zang R; Case JB; Zheng W; Ding S; Liang TJ mBio; 2022 Feb; 13(1):e0323821. PubMed ID: 35012356 [TBL] [Abstract][Full Text] [Related]
15. The Integral Membrane Protein ZMPSTE24 Protects Cells from SARS-CoV-2 Spike-Mediated Pseudovirus Infection and Syncytia Formation. Shilagardi K; Spear ED; Abraham R; Griffin DE; Michaelis S mBio; 2022 Oct; 13(5):e0254322. PubMed ID: 36197088 [TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 Omicron entry is type II transmembrane serine protease-mediated in human airway and intestinal organoid models. Mykytyn AZ; Breugem TI; Geurts MH; Beumer J; Schipper D; van Acker R; van den Doel PB; van Royen ME; Zhang J; Clevers H; Haagmans BL; Lamers MM J Virol; 2023 Aug; 97(8):e0085123. PubMed ID: 37555660 [TBL] [Abstract][Full Text] [Related]
18. Analysis of the Role of N-Linked Glycosylation in Cell Surface Expression, Function, and Binding Properties of SARS-CoV-2 Receptor ACE2. Rowland R; Brandariz-Nuñez A Microbiol Spectr; 2021 Oct; 9(2):e0119921. PubMed ID: 34494876 [TBL] [Abstract][Full Text] [Related]
19. Inhibition Mechanism of SARS-CoV-2 Infection by a Cholesterol Derivative, Nat-20(S)-yne. Murae M; Sakai S; Miyata N; Shimizu Y; Okemoto-Nakamura Y; Kishimoto T; Ogawa M; Tani H; Tanaka K; Noguchi K; Fukasawa M Biol Pharm Bull; 2024; 47(5):930-940. PubMed ID: 38692871 [TBL] [Abstract][Full Text] [Related]